{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:42:29Z","timestamp":1792190549266,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ncrna.2022.02.002","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T21:24:41Z","timestamp":1649539481000},"page":"114-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Unique circulating microRNA profiles in epidemic Kaposi's sarcoma"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3964-2169","authenticated-orcid":false,"given":"Haruna","family":"Muwonge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Kasujja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nixon","family":"Niyonzima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4960-7228","authenticated-orcid":false,"given":"Carolyne","family":"Atugonza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Kasolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4841-0538","authenticated-orcid":false,"given":"Allan","family":"Lugaajju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Nfambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-4077","authenticated-orcid":false,"given":"Sembajwe Larry","family":"Fred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Moses","family":"Damani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Kimuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zavuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Nakazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Kigozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damalie","family":"Nakanjako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Patrick","family":"Kateete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddie","family":"Bwanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ncrna.2022.02.002_bib1","doi-asserted-by":"crossref","first-page":"e13936","DOI":"10.1371\/journal.pone.0013936","article-title":"Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda","volume":"5","author":"Phipps","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ncrna.2022.02.002_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/QAI.0b013e318251aedd","article-title":"A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa","volume":"60","author":"Mosam","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ncrna.2022.02.002_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12885-016-2080-0","article-title":"Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan Africa","volume":"16","author":"Freeman","year":"2016","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ncrna.2022.02.002_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/QAI.0000000000001286","article-title":"Evaluation of a predictive staging model for HIV-associated Kaposi sarcoma in Uganda","volume":"74","author":"Okuku","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"11","key":"10.1016\/j.ncrna.2022.02.002_bib5","first-page":"23","article-title":"Kaposi sarcoma as a cutaneous vasculitis mimic: diagnosis and treatment","volume":"12","author":"Yaqub","year":"2019","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.ncrna.2022.02.002_bib6","series-title":"Diagnosis and Antiviral Therapy of Human Herpesvirus 8 Infection","author":"Corey","year":"2019"},{"issue":"3","key":"10.1016\/j.ncrna.2022.02.002_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/QAI.0000000000000862","article-title":"Accuracy of clinical suspicion and pathologic diagnosis of Kaposi sarcoma in East Africa","volume":"71","author":"Amerson","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.ncrna.2022.02.002_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/CMR.15.3.439-464.2002","article-title":"Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases","volume":"15","author":"Ablashi","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.ncrna.2022.02.002_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.semdp.2017.04.004","article-title":"Human herpesvirus 8-related diseases: histopathologic diagnosis and disease mechanisms","volume":"34","author":"Auten","year":"2017","journal-title":"Semin. Diagn. Pathol."},{"issue":"4","key":"10.1016\/j.ncrna.2022.02.002_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41374-018-0143-3","article-title":"MicroRNA amplification and detection technologies: opportunities and challenges for point of care diagnostics","volume":"99","author":"Dave","year":"2019","journal-title":"Lab. Invest."},{"issue":"402","key":"10.1016\/j.ncrna.2022.02.002_bib11","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.ncrna.2022.02.002_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jmoldx.2012.03.004","article-title":"Classification of the four main types of lung cancer using a MicroRNA-based diagnostic assay","volume":"14","author":"Gilad","year":"2012","journal-title":"J. Mol. Diagn."},{"issue":"5","key":"10.1016\/j.ncrna.2022.02.002_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.beem.2016.07.002","article-title":"microRNA-guided diagnostics in clinical samples","volume":"30","author":"Gustafson","year":"2016","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"17","key":"10.1016\/j.ncrna.2022.02.002_bib14","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ncrna.2022.02.002_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ygyno.2009.04.024","article-title":"Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients","volume":"114","author":"Eitan","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"15","key":"10.1016\/j.ncrna.2022.02.002_bib16","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJMoa0901282","article-title":"MicroRNA expression, survival, and response to interferon in liver cancer","volume":"361","author":"Ji","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ncrna.2022.02.002_bib17","first-page":"281","article-title":"Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue","volume":"6","author":"Ahmed","year":"2009","journal-title":"CANCER GENOMICS PROTEOMICS"},{"issue":"11","key":"10.1016\/j.ncrna.2022.02.002_bib18","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.3390\/v6114571","article-title":"Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis","volume":"6","author":"Qin","year":"2014","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.ncrna.2022.02.002_bib19","doi-asserted-by":"crossref","first-page":"e0162574","DOI":"10.1371\/journal.pone.0162574","article-title":"Profile of exosomal and intracellular microRNA in gamma-herpesvirus-infected lymphoma cell lines","volume":"11","author":"Hoshina","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ncrna.2022.02.002_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1590\/1516-3180.2014.8973010","article-title":"Human herpesvirus 8 (HHV-8) detected by nested polymerase chain reaction (PCR) in HIV patients with or without Kaposi's sarcoma. An analytic cross-sectional study","volume":"134","author":"Machado","year":"2015","journal-title":"Sao Paulo Med. J."},{"issue":"1","key":"10.1016\/j.ncrna.2022.02.002_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12859-018-2287-y","article-title":"miRge 2.0 for comprehensive analysis of microRNA sequencing data","volume":"19","author":"Lu","year":"2018","journal-title":"BMC Bioinf."},{"issue":"1","key":"10.1016\/j.ncrna.2022.02.002_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ncrna.2022.02.002_bib23","doi-asserted-by":"crossref","first-page":"D140","DOI":"10.1093\/nar\/gkj112","article-title":"miRBase: microRNA sequences, targets and gene nomenclature","volume":"34","author":"Griffiths-Jones","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ncrna.2022.02.002_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12985-017-0743-3","article-title":"Proof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection","volume":"14","author":"Stenfeldt","year":"2017","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.ncrna.2022.02.002_bib25","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","article-title":"Assessing sample and miRNA profile quality in serum and plasma or other biofluids","volume":"59","author":"Blondal","year":"2013","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.ncrna.2022.02.002_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13148-018-0492-1","article-title":"Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage","volume":"10","author":"Wang","year":"2018","journal-title":"Clin. Epigenet."},{"issue":"10","key":"10.1016\/j.ncrna.2022.02.002_bib27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.ncrna.2022.02.002_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fgene.2013.00119","article-title":"Circulating miRNAs: cell-cell communication function?","volume":"4","author":"Turchinovich","year":"2013","journal-title":"Front. Genet."},{"issue":"3","key":"10.1016\/j.ncrna.2022.02.002_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030415","article-title":"Circulating MicroRNA biomarkers for lung cancer detection in East Asian populations","volume":"11","author":"Yu","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ncrna.2022.02.002_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/193860","article-title":"Mechanisms of Kaposi's sarcoma-associated herpesvirus latency and reactivation","volume":"2011","author":"Ye","year":"2011","journal-title":"Adv. Virol."},{"issue":"5","key":"10.1016\/j.ncrna.2022.02.002_bib31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ncb2054","article-title":"miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator","volume":"12","author":"Lagos","year":"2010","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.ncrna.2022.02.002_bib32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13046-017-0649-3","article-title":"Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel","volume":"36","author":"Yang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ncrna.2022.02.002_bib33","doi-asserted-by":"crossref","first-page":"e1006143","DOI":"10.1371\/journal.ppat.1006143","article-title":"RNA sequencing reveals that Kaposi sarcoma-associated herpesvirus infection mimics hypoxia gene expression signature","volume":"13","author":"Viollet","year":"2017","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.ncrna.2022.02.002_bib34","first-page":"175","article-title":"Extracellular\/circulating MicroRNAs: release mechanisms, functions and challenges","volume":"10","author":"Sohel","year":"2016","journal-title":"Achiev. Life Sci."},{"issue":"1","key":"10.1016\/j.ncrna.2022.02.002_bib35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s13277-014-2626-1","article-title":"The expression profiles of microRNAs in Kaposi's sarcoma","volume":"36","author":"Wu","year":"2015","journal-title":"Tumour Biol."},{"issue":"12","key":"10.1016\/j.ncrna.2022.02.002_bib36","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/onc.2009.460","article-title":"Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a","volume":"29","author":"Punj","year":"2010","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.ncrna.2022.02.002_bib37","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1007\/s00705-017-3478-y","article-title":"Profiling of cellular microRNA responses during the early stages of KSHV infection","volume":"162","author":"Hussein","year":"2017","journal-title":"Arch. Virol."},{"issue":"16","key":"10.1016\/j.ncrna.2022.02.002_bib38","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1242\/jcs.077529","article-title":"MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2","volume":"124","author":"Shatseva","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ncrna.2022.02.002_bib39","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.3389\/fmicb.2018.03185","article-title":"Potential application of MicroRNA profiling to the diagnosis and prognosis of HIV-1 infection","volume":"9","author":"Su","year":"2018","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.ncrna.2022.02.002_bib40","article-title":"MicroRNA profiling in plasma of HIV-1 infected patients: potential markers of infection and immune status","volume":"1","author":"Qi","year":"2017","journal-title":"J. Publ. Health Epidemiol."},{"issue":"5","key":"10.1016\/j.ncrna.2022.02.002_bib41","doi-asserted-by":"crossref","first-page":"e95920","DOI":"10.1371\/journal.pone.0095920","article-title":"MicroRNA-150 is a potential biomarker of HIV\/AIDS disease progression and therapy","volume":"9","author":"Munshi","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ncrna.2022.02.002_bib42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jcp.25131","article-title":"Defining plasma MicroRNAs associated with cognitive impairment in HIV-infected patients","volume":"231","author":"Kadri","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.ncrna.2022.02.002_bib43","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/jac\/dkg199","article-title":"How does HAART lead to the resolution of Kaposi's sarcoma?","volume":"51","author":"Stebbing","year":"2003","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054022000075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054022000075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:28:21Z","timestamp":1762835301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054022000075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2468054022000075"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2022.02.002","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-116856\/v1","asserted-by":"object"}]},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unique circulating microRNA profiles in epidemic Kaposi's sarcoma","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2022.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}